UBS raises MiniMed Group price target to $28 from $25
UBS maintained a Buy rating on MiniMed Group and raised its price target to $28.00 per share from $25.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.